The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Head and Neck Cancer (HNC) Therapeutic Market Research Report 2024
Synopsis
Global Head and Neck Cancer (HNC) Therapeutic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Head and Neck Cancer (HNC) Therapeutic market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Head and Neck Cancer (HNC) Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eli Lilly
Sanofi
Merck & Co.
Clinigen Group
Bristol-Myers Squibb
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Hoffmann-La Roche
Coherus BioSciences
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Head and Neck Cancer (HNC) Therapeutic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Head and Neck Cancer (HNC) Therapeutic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Head and Neck Cancer (HNC) Therapeutic market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Head and Neck Cancer (HNC) Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eli Lilly
Sanofi
Merck & Co.
Clinigen Group
Bristol-Myers Squibb
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Hoffmann-La Roche
Coherus BioSciences
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Head and Neck Cancer (HNC) Therapeutic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.3 Market by Application
1.3.1 Global Head and Neck Cancer (HNC) Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Head and Neck Cancer (HNC) Therapeutic Market Perspective (2018-2029)
2.2 Head and Neck Cancer (HNC) Therapeutic Growth Trends by Region
2.2.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Head and Neck Cancer (HNC) Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Head and Neck Cancer (HNC) Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Head and Neck Cancer (HNC) Therapeutic Market Dynamics
2.3.1 Head and Neck Cancer (HNC) Therapeutic Industry Trends
2.3.2 Head and Neck Cancer (HNC) Therapeutic Market Drivers
2.3.3 Head and Neck Cancer (HNC) Therapeutic Market Challenges
2.3.4 Head and Neck Cancer (HNC) Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Head and Neck Cancer (HNC) Therapeutic Players by Revenue
3.1.1 Global Top Head and Neck Cancer (HNC) Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Head and Neck Cancer (HNC) Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Head and Neck Cancer (HNC) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Head and Neck Cancer (HNC) Therapeutic Revenue
3.4 Global Head and Neck Cancer (HNC) Therapeutic Market Concentration Ratio
3.4.1 Global Head and Neck Cancer (HNC) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Head and Neck Cancer (HNC) Therapeutic Revenue in 2022
3.5 Head and Neck Cancer (HNC) Therapeutic Key Players Head office and Area Served
3.6 Key Players Head and Neck Cancer (HNC) Therapeutic Product Solution and Service
3.7 Date of Enter into Head and Neck Cancer (HNC) Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Head and Neck Cancer (HNC) Therapeutic Breakdown Data by Type
4.1 Global Head and Neck Cancer (HNC) Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Head and Neck Cancer (HNC) Therapeutic Forecasted Market Size by Type (2024-2029)
5 Head and Neck Cancer (HNC) Therapeutic Breakdown Data by Application
5.1 Global Head and Neck Cancer (HNC) Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Head and Neck Cancer (HNC) Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Head and Neck Cancer (HNC) Therapeutic Market Size (2018-2029)
6.2 North America Head and Neck Cancer (HNC) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2018-2023)
6.4 North America Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Head and Neck Cancer (HNC) Therapeutic Market Size (2018-2029)
7.2 Europe Head and Neck Cancer (HNC) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2018-2023)
7.4 Europe Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Head and Neck Cancer (HNC) Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Head and Neck Cancer (HNC) Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Head and Neck Cancer (HNC) Therapeutic Market Size (2018-2029)
9.2 Latin America Head and Neck Cancer (HNC) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Head and Neck Cancer (HNC) Therapeutic Introduction
11.1.4 Eli Lilly Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Head and Neck Cancer (HNC) Therapeutic Introduction
11.2.4 Sanofi Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Head and Neck Cancer (HNC) Therapeutic Introduction
11.3.4 Merck & Co. Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.3.5 Merck & Co. Recent Development
11.4 Clinigen Group
11.4.1 Clinigen Group Company Detail
11.4.2 Clinigen Group Business Overview
11.4.3 Clinigen Group Head and Neck Cancer (HNC) Therapeutic Introduction
11.4.4 Clinigen Group Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.4.5 Clinigen Group Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Introduction
11.5.4 Bristol-Myers Squibb Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Head and Neck Cancer (HNC) Therapeutic Introduction
11.6.4 AstraZeneca Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Introduction
11.7.4 Takeda Pharmaceutical Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Detail
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Hoffmann-La Roche
11.9.1 Hoffmann-La Roche Company Detail
11.9.2 Hoffmann-La Roche Business Overview
11.9.3 Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Introduction
11.9.4 Hoffmann-La Roche Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.9.5 Hoffmann-La Roche Recent Development
11.10 Coherus BioSciences
11.10.1 Coherus BioSciences Company Detail
11.10.2 Coherus BioSciences Business Overview
11.10.3 Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Introduction
11.10.4 Coherus BioSciences Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
11.10.5 Coherus BioSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
